Literature DB >> 10424743

Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes.

G M Taylor1, D A Gokhale, D Crowther, P J Woll, M Harris, D Ryder, M Ayres, J A Radford.   

Abstract

It has been suggested in a number of studies that susceptibility to adult Hodgkin's disease (HD) is influenced by the HLA class II region, and specifically by alleles at the HLA-DPB1 locus. Since HD is diagnostically complex, it is not clear whether different HLA-DPB1 alleles confer susceptibility to different HD subtypes. To clarify this we have extended a previous study to type DPB1 alleles in 147 adult HD patients from a single centre. We have analysed patients with nodular sclerosing (NS), mixed cellularity (MC) or lymphocyte predominant (LP) HD, and gender in relation to HLA-DPB1 type, in comparison with 183 adult controls. The results confirmed previously reported associations of DPB1*0301 with HD susceptibility (relative risk (RR) = 1.42; 95% confidence interval (CI) 0.86-2.36) and DPB1*0201 with resistance to HD (RR = 0.49; CI 0.27-0.90). However, analysis by HD subtype and gender showed that *0301-associated susceptibility was confined to females with HD (RR = 2.46; CI 1.02-5.92), and *0201-associated resistance to females with NS-HD (RR = 0.28; CI 0.10-0.79). Susceptibility to NS-HD was also associated in females with *1001 (RR = 11.73; CI 1.32-104.36), and resistance with *1101 (RR = 0.08; CI 0.01-0.65). In contrast, susceptibility to LP-HD was associated in males with *2001 (RR = 32.14; CI 3.17-326.17), and to MC-HD with *3401 (RR = 16.78; CI 2.84-99.17). Comparison of DPB1-encoded polymorphic amino-acid frequencies in patients and controls showed that susceptibility to MC-HD was associated with Leucine at position 35 of DPB1 (RR = 8.85; CI 3.04-25.77), Alanine-55 (RR = 15.17; CI 2.00-115.20) and Valine-84 (RR = 15.94; CI 3.55-71.49). In contrast, Glutamic acid 69 was significantly associated with resistance to MC-HD (RR = 0.14; CI 0.03-0.60). Certain DPB1 alleles and individual DPbeta1 polymorphic amino acid residues may thus affect susceptibility and resistance to specific HD subtypes. This may be through their influence on the binding of peptides derived from an HD-associated infectious agent, and the consequent effect on immune responses to the agent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424743      PMCID: PMC2363076          DOI: 10.1038/sj.bjc.6690536

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  35 in total

Review 1.  New methods to predict MHC-binding sequences within protein antigens.

Authors:  J Hammer
Journal:  Curr Opin Immunol       Date:  1995-04       Impact factor: 7.486

2.  Nomenclature for factors of the HLA system, update May/June 1997. WHO Nomenclature Committee for Factors of the HLA System.

Authors:  S G Marsh
Journal:  Tissue Antigens       Date:  1997-10

Review 3.  The epidemiology of Hodgkin's disease.

Authors:  S L Glaser; R F Jarrett
Journal:  Baillieres Clin Haematol       Date:  1996-09

Review 4.  Is Hodgkin's disease infectious?

Authors:  N J Vianna
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

5.  Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association.

Authors:  J Hammer; F Gallazzi; E Bono; R W Karr; J Guenot; P Valsasnini; Z A Nagy; F Sinigaglia
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

6.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

7.  Combination of log relative risk in retrospective studies of disease.

Authors:  P R Sheehe
Journal:  Am J Public Health Nations Health       Date:  1966-10

8.  Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease.

Authors:  J A Radford; D Crowther; A Z Rohatiner; W D Ryder; R K Gupta; A Oza; D P Deakin; S Arnott; P M Wilkinson; R D James
Journal:  J Clin Oncol       Date:  1995-09       Impact factor: 44.544

9.  Presence of Epstein-Barr virus in Hodgkin's disease is not exclusive to Reed-Sternberg cells.

Authors:  G Khan; P J Coates; R K Gupta; H O Kangro; G Slavin
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

10.  Nodular lymphocyte predominance Hodgkin's disease: a monoclonal or polyclonal B-cell disorder?

Authors:  L X Pan; T C Diss; H Z Peng; A J Norton; P G Isaacson
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

View more
  8 in total

1.  Multi-locus HLA class I and II allele and haplotype associations with follicular lymphoma.

Authors:  C F Skibola; N K Akers; L Conde; M Ladner; S K Hawbecker; F Cohen; F Ribas; H A Erlich; D Goodridge; E A Trachtenberg; M T Smith; P M Bracci
Journal:  Tissue Antigens       Date:  2012-02-02

Review 2.  Genetic susceptibility to lymphoma.

Authors:  Christine F Skibola; John D Curry; Alexandra Nieters
Journal:  Haematologica       Date:  2007-07       Impact factor: 9.941

3.  Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.

Authors:  Kevin Y Urayama; Ruth F Jarrett; Henrik Hjalgrim; Arjan Diepstra; Yoichiro Kamatani; Amelie Chabrier; Valerie Gaborieau; Anne Boland; Alexandra Nieters; Nikolaus Becker; Lenka Foretova; Yolanda Benavente; Marc Maynadié; Anthony Staines; Lesley Shield; Annette Lake; Dorothy Montgomery; Malcolm Taylor; Karin Ekström Smedby; Rose-Marie Amini; Hans-Olov Adami; Bengt Glimelius; Bjarke Feenstra; Ilja M Nolte; Lydia Visser; Gustaaf W van Imhoff; Tracy Lightfoot; Pierluigi Cocco; Lambertus Kiemeney; Sita H Vermeulen; Ivana Holcatova; Lars Vatten; Gary J Macfarlane; Peter Thomson; David I Conway; Simone Benhamou; Antonio Agudo; Claire M Healy; Kim Overvad; Anne Tjønneland; Beatrice Melin; Federico Canzian; Kay-Tee Khaw; Ruth C Travis; Petra H M Peeters; Carlos A González; José Ramón Quirós; María-José Sánchez; José María Huerta; Eva Ardanaz; Miren Dorronsoro; Françoise Clavel-Chapelon; H Bas Bueno-de-Mesquita; Elio Riboli; Eve Roman; Paolo Boffetta; Silvia de Sanjosé; Diana Zelenika; Mads Melbye; Anke van den Berg; Mark Lathrop; Paul Brennan; James D McKay
Journal:  J Natl Cancer Inst       Date:  2012-01-27       Impact factor: 13.506

4.  Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.

Authors:  Christine F Skibola; Sonja I Berndt; Joseph Vijai; Lucia Conde; Zhaoming Wang; Meredith Yeager; Paul I W de Bakker; Brenda M Birmann; Claire M Vajdic; Jia-Nee Foo; Paige M Bracci; Roel C H Vermeulen; Susan L Slager; Silvia de Sanjose; Sophia S Wang; Martha S Linet; Gilles Salles; Qing Lan; Gianluca Severi; Henrik Hjalgrim; Tracy Lightfoot; Mads Melbye; Jian Gu; Hervé Ghesquières; Brian K Link; Lindsay M Morton; Elizabeth A Holly; Alex Smith; Lesley F Tinker; Lauren R Teras; Anne Kricker; Nikolaus Becker; Mark P Purdue; John J Spinelli; Yawei Zhang; Graham G Giles; Paolo Vineis; Alain Monnereau; Kimberly A Bertrand; Demetrius Albanes; Anne Zeleniuch-Jacquotte; Attilio Gabbas; Charles C Chung; Laurie Burdett; Amy Hutchinson; Charles Lawrence; Rebecca Montalvan; Liming Liang; Jinyan Huang; Baoshan Ma; Jianjun Liu; Hans-Olov Adami; Bengt Glimelius; Yuanqing Ye; Grzegorz S Nowakowski; Ahmet Dogan; Carrie A Thompson; Thomas M Habermann; Anne J Novak; Mark Liebow; Thomas E Witzig; George J Weiner; Maryjean Schenk; Patricia Hartge; Anneclaire J De Roos; Wendy Cozen; Degui Zhi; Nicholas K Akers; Jacques Riby; Martyn T Smith; Mortimer Lacher; Danylo J Villano; Ann Maria; Eve Roman; Eleanor Kane; Rebecca D Jackson; Kari E North; W Ryan Diver; Jenny Turner; Bruce K Armstrong; Yolanda Benavente; Paolo Boffetta; Paul Brennan; Lenka Foretova; Marc Maynadie; Anthony Staines; James McKay; Angela R Brooks-Wilson; Tongzhang Zheng; Theodore R Holford; Saioa Chamosa; Rudolph Kaaks; Rachel S Kelly; Bodil Ohlsson; Ruth C Travis; Elisabete Weiderpass; Jacqueline Clavel; Edward Giovannucci; Peter Kraft; Jarmo Virtamo; Patrizio Mazza; Pierluigi Cocco; Maria Grazia Ennas; Brian C H Chiu; Joseph F Fraumeni; Alexandra Nieters; Kenneth Offit; Xifeng Wu; James R Cerhan; Karin E Smedby; Stephen J Chanock; Nathaniel Rothman
Journal:  Am J Hum Genet       Date:  2014-10-02       Impact factor: 11.043

5.  Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.

Authors:  Paul C D Johnson; Karen A McAulay; Dorothy Montgomery; Annette Lake; Lesley Shield; Alice Gallagher; Ann-Margaret Little; Anila Shah; Steven G E Marsh; G Malcolm Taylor; Ruth F Jarrett
Journal:  Int J Cancer       Date:  2015-02-20       Impact factor: 7.396

6.  Association of HLA-DQB1*0301 and HLA-DQB1*0602 with different subtypes of gastric cancer in Taiwan.

Authors:  Ming-Shiang Wu; Rhong-Phong Hsieh; Shih-Pei Huang; Yu-Ting Chang; Ming-Tsan Lin; Ming-Chu Chang; Chia-Tung Shun; Jin-Chuan Sheu; Jaw-Town Lin
Journal:  Jpn J Cancer Res       Date:  2002-04

7.  Association of Single-Nucleotide Variants in the Human Leukocyte Antigen and Other Loci With Childhood Hodgkin Lymphoma.

Authors:  Cheng Chen; Nan Song; Qian Dong; Xiaojun Sun; Heather L Mulder; John Easton; Jinghui Zhang; Yutaka Yasui; Smita Bhatia; Gregory T Armstrong; Hui Wang; Kirsten K Ness; Melissa M Hudson; Leslie L Robison; Zhaoming Wang
Journal:  JAMA Netw Open       Date:  2022-08-01

8.  Phenotypic Selection of Dairy Cattle Infected with Bovine Leukemia Virus Demonstrates Immunogenetic Resilience through NGS-Based Genotyping of BoLA MHC Class II Genes.

Authors:  Chaelynne E Lohr; Kelly R B Sporer; Kelsey A Brigham; Laura A Pavliscak; Matelyn M Mason; Andrew Borgman; Vickie J Ruggiero; Tasia M Taxis; Paul C Bartlett; Casey J Droscha
Journal:  Pathogens       Date:  2022-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.